Your browser doesn't support javascript.
loading
Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML.
Ling, Qing; Zhou, Yutong; Qian, Yu; Qian, Jiejing; Zhang, Yi; Wang, Jinghan; Zhu, Yanan; Zhou, Yile; Wei, Juying; Yang, Chunmei; Sun, Jie; Yu, Wenjuan; Jin, Jie; Zhang, Xiang.
Affiliation
  • Ling Q; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, #79 Qingchun Rd, Hangzhou, 310003, Zhejiang, China.
  • Zhou Y; Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, 310003, Zhejiang, P. R. China.
  • Qian Y; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, 310003, Zhejiang, P. R. China.
  • Qian J; Zhejiang University Cancer Center, Hangzhou, 310003, Zhejiang, P. R. China.
  • Zhang Y; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, #79 Qingchun Rd, Hangzhou, 310003, Zhejiang, China.
  • Wang J; Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, 310003, Zhejiang, P. R. China.
  • Zhu Y; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, 310003, Zhejiang, P. R. China.
  • Zhou Y; Zhejiang University Cancer Center, Hangzhou, 310003, Zhejiang, P. R. China.
  • Wei J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, #79 Qingchun Rd, Hangzhou, 310003, Zhejiang, China.
  • Yang C; Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, 310003, Zhejiang, P. R. China.
  • Sun J; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, 310003, Zhejiang, P. R. China.
  • Yu W; Zhejiang University Cancer Center, Hangzhou, 310003, Zhejiang, P. R. China.
  • Jin J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, #79 Qingchun Rd, Hangzhou, 310003, Zhejiang, China.
  • Zhang X; Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, 310003, Zhejiang, P. R. China.
Biomark Res ; 11(1): 105, 2023 Dec 05.
Article in En | MEDLINE | ID: mdl-38053201
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomark Res Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomark Res Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom